首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1746892

日本流感診斷市場報告（按產品、檢測類型、流感類型、最終用戶和地區）2025 年至 2033 年

Japan Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本流感診斷市場規模達6,320萬美元。展望未來， IMARC Group預計到2033年，該市場規模將達到1.05億美元，2025-2033年期間的複合年成長率（CAGR）為5.3%。推動該市場發展的因素包括疫苗接種活動的擴大、即時檢測的便利性、流感病毒研究的深入以及公共衛生舉措帶來的認知提升。

流感，通常簡稱為流感，是一種主要攻擊呼吸系統的病毒性感染，會影響鼻腔、喉嚨和肺部等部位。流感診斷涵蓋多種免疫測定檢測，旨在檢測呼吸道檢體中甲型和乙型流感病毒的核蛋白抗原。可用的診斷方法包括快速抗原檢測、逆轉錄聚合酶鍊式反應 (RT-PCR)、免疫螢光檢測、血清學檢測和快速分子檢測。醫療專業人員依靠這些診斷方法快速識別和分類流感病毒株，從而促進有效的治療決策並實現高效的公共衛生管理。

日本流感診斷市場趨勢：

日本流感診斷市場正經歷大幅成長，這得益於多種因素的共同推動。其中最主要的是流感疫情的不斷增加，這使得有效的診斷解決方案變得至關重要。此外，人們對全球大流行可能性的日益擔憂，也刺激了對診斷能力的投資，為市場擴張做出了重大貢獻。此外，該領域的持續技術進步正在提高診斷測試的準確性和速度，從而對市場的成長軌跡產生了積極的影響。此外，以及時檢測的重要性為重點的公眾意識宣傳活動，鼓勵了更多人尋求診斷服務，進一步刺激了市場需求。日本不斷成長的醫療保健支出支持了先進診斷方法的採用，從而促進了市場成長。此外，更容易患重症流感的長者也推動了對診斷服務的需求成長。日本城市人口的成長導致感染率上升，凸顯了對強大診斷解決方案的需求。頻繁的國內和國際旅行加速了流感的傳播，進一步凸顯了高效診斷的重要性。這些因素將在預測期內共同為日本流感診斷市場創造大量機會。

日本流感診斷市場細分：

產品洞察：

檢測試劑盒和試劑
儀器
其他

測試類型洞察：

分子診斷測試
- 聚合酶鍊式反應
- 等溫核酸擴增試驗
- 其他
傳統診斷測試
- 快速流感診斷測試
- 病毒培養測試
- 直接螢光抗體檢測
- 血清學檢測

流感洞察類型：

A型流感
B型流感
C型流感

最終用戶洞察：

醫院
診斷實驗室
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本流感診斷市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本流感診斷市場有何影響？
日本流感診斷市場依產品分類是怎樣的？
根據檢測類型，日本流感診斷市場是如何分類的？
日本流感診斷市場根據流感類型如何分類？
根據最終用戶，日本流感診斷市場是如何分佈的？
日本流感診斷市場的價值鏈分為哪些階段？
日本流感診斷的主要促進因素和挑戰是什麼？
日本流感診斷市場的結構是怎麼樣的？主要參與者是誰？
日本流感診斷市場的競爭程度如何？

本報告回答的關鍵問題：

日本流感診斷市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本流感診斷市場有何影響？
日本流感診斷市場依產品分類是怎樣的？
根據檢測類型，日本流感診斷市場是如何分類的？
日本流感診斷市場根據流感類型如何分類？
根據最終用戶，日本流感診斷市場是如何分佈的？
日本流感診斷市場的價值鏈分為哪些階段？
日本流感診斷的主要促進因素和挑戰是什麼？
日本流感診斷市場的結構是怎麼樣的？主要參與者是誰？
日本流感診斷市場的競爭程度如何？

Japan influenza diagnostics market size reached USD 63.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 105.0 Million by 2033, exhibiting a growth rate (CAGR) of 5.3% during 2025-2033. The market is being driven by several factors, including the expansion of vaccination campaigns, the convenience offered by point-of-care testing, intensified research into influenza viruses, and increased awareness through public health initiatives.

Influenza, commonly referred to as the flu, is a viral infection that primarily targets the respiratory system, affecting areas such as the nose, throat, and lungs. The realm of influenza diagnostics encompasses a variety of immunoassay tests designed to detect the presence of nucleoprotein antigens from influenza A and B viruses in respiratory samples. Among the available diagnostic methods are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serological tests, and rapid molecular assays. These diagnostic options are relied upon by healthcare professionals to promptly identify and categorize influenza strains, facilitating effective treatment decisions and enabling efficient public health management.

Japan Influenza Diagnostics Market Trends:

The influenza diagnostics market in Japan is witnessing substantial growth, driven by a combination of factors. Foremost among these is the increasing incidence of flu outbreaks, which necessitates effective diagnostic solutions. Apart from this, the growing concerns regarding the potential for pandemics have spurred investments in diagnostic capabilities, making a significant contribution to market expansion. Furthermore, continuous technological advancements in the field are enhancing the accuracy and speed of diagnostic tests, positively impacting the market's growth trajectory. Besides this, public awareness campaigns focused on the importance of timely testing have encouraged more individuals to seek diagnostic services, further catalyzing market demand. Japan's rising healthcare spending supports the adoption of advanced diagnostic methods, contributing to market growth. Additionally, elderly individuals, who are more vulnerable to severe cases of the flu, are driving increased demand for diagnostic services. The growth of urban populations in Japan has led to higher infection rates, underscoring the need for robust diagnostic solutions. Frequent travel within the country and internationally has accelerated the spread of the flu, further highlighting the importance of efficient diagnostics. These factors will collectively create numerous opportunities for the influenza diagnostics market in Japan over the forecasted period.

Japan Influenza Diagnostics Market Segmentation:

Product Insights:

Test Kit and Reagents
Instruments
Others

Test Type Insights:

Molecular Diagnostic Tests
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Tests
- Others
Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests
- Viral Culture Tests
- Direct Fluorescent Antibody Test
- Serological Tests

Type of Flu Insights:

Type A Flu
Type B Flu
Type C Flu

End User Insights:

Hospitals
Diagnostic Laboratories
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan influenza diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan influenza diagnostics market?
What is the breakup of the Japan influenza diagnostics market on the basis of product?
What is the breakup of the Japan influenza diagnostics market on the basis of test type?
What is the breakup of the Japan influenza diagnostics market on the basis of type of flu?
What is the breakup of the Japan influenza diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan influenza diagnostics market?
What are the key driving factors and challenges in the Japan influenza diagnostics?
What is the structure of the Japan influenza diagnostics market and who are the key players?
What is the degree of competition in the Japan influenza diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Influenza Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Influenza Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Influenza Diagnostics Market - Breakup by Product

6.1 Test Kit and Reagents
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Others
- 6.3.1 Historical and Current Market Trends (2019-2024)
- 6.3.2 Market Forecast (2025-2033)

7 Japan Influenza Diagnostics Market - Breakup by Test Type

7.1 Molecular Diagnostic Tests
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Polymerase Chain Reaction
  - 7.1.3.2 Isothermal Nucleic Acid Amplification Tests
  - 7.1.3.3 Others
- 7.1.4 Market Forecast (2025-2033)
7.2 Traditional Diagnostic Tests
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Rapid Influenza Diagnostic Tests
  - 7.2.3.2 Viral Culture Tests
  - 7.2.3.3 Direct Fluorescent Antibody Test
  - 7.2.3.4 Serological Tests
- 7.2.4 Market Forecast (2025-2033)

8 Japan Influenza Diagnostics Market - Breakup by Type of Flu

8.1 Type A Flu
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Type B Flu
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Type C Flu
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Influenza Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Influenza Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Influenza Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis